News | News By Subject | News by Disease News By Date | Search News

Cardiovascular Disorder (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Servier Release: European Medicines Agency Recommends Measures To Reduce Risk Of Heart Problems With Corlentor/Procoralan (Ivabradine)     11/21/2014
Sanofi And Regeneron's Alirocumab Ph3 Trials Met Primary Efficacy Endpoint     11/20/2014
Merck & Co.'s Vytorin Proves Effective; IMPROVE-IT Trial Achieves Primary Endpoint     11/19/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
ZS Pharma Presents Positive Results From HARMONIZE (ZS004), A Second Phase 3 Clinical Trial Of ZS-9 In Patients With Hyperkalemia, At The American Heart Association Scientific Meeting And Announces Simultaneous Publication Of Results In JAMA     11/17/2014
Alnylam Pharmaceuticals Reports Positive Initial Phase 2 Data With Revusiran     11/14/2014
Boehringer Ingelheim Corporation Passes on Anthera, Inc.'s CV Antibody Option     11/13/2014
AstraZeneca PLC To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta     11/13/2014
Cardiome Pharma Corp. Touts Positive Data From Phase 3 BRINAVESS® Trial     11/7/2014
FDA Panel Backs Daiichi Sankyo, Inc.'s New A-Fib Drug Savaysa     10/31/2014
Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France)     9/17/2014
Wall Street Overreacting To Amarin Denial: Citigroup Analyst     9/12/2014
Amgen, Servier Heart Drug Runs Into Safety Concerns In Major Clinical Study     9/4/2014
Resverlogix Corporation's RVX-208 Leads To A 77 Percent Relative Risk Reduction Of Major Heart Events     9/2/2014

Featured Stories
Only 4 In 10 Americans Eat Heart-Healthy Nuts Each Day, CDC Says     12/18/2014
Yoga May Guard Against Heart Disease, Erasmus MC Study Finds     12/17/2014
Obesity May Shorten Life Expectancy Up To 8 Years, McGill University Study     12/9/2014
Natural Substance In Red Wine Has An Anti-Inflammatory Effect In Cardiovascular Diseases, Johannes Gutenberg University Study     12/5/2014
Emotional Stress Affects Women's Heart More, Emory University Study     11/17/2014
Long Term Shift Work Linked To Impaired Brain Function, Occupational & Environmental Medicine Reveals     11/5/2014
Mental Health Disorders Double Heart Disease, Stroke Risk, Centre For Addiction And Mental Health Study     10/28/2014
Drinking Two Sodas A Day Can Age You 4 Years, University of California, San Francisco (UCSF) Study     10/21/2014
How Omega-6 Fatty Acids Lower Bad Cholesterol, Innsbruck Medical University Study     10/20/2014
Americans Living Longer As Fewer Die From Heart Disease, Cancer, CDC Reveals     10/13/2014
How To Predict Who Will Suffer The Most From Stress, Concordia University Study     10/2/2014
Healthy Fats Help Diseased Heart Muscle Process, Use Fuel, University of Illinois Study     10/1/2014
Cardiorespiratory Fitness Slashes High Blood Pressure Hikes In Men, University of South Carolina Study     9/17/2014
Inflammation May Be Key To Diabetes/Heart Disease Link, Universidad Autónoma de Madrid Study     9/16/2014
Short Walking Breaks Reverse Harmful Effects Of Prolonged Sitting, Indiana University Study     9/10/2014

More News
Amarantus BioSciences, Inc. Submits Orphan Drug Designation Application To U.S. FDA For Treatment Of Retinal Artery Occlusion With Product Candidate MANF     12/19/2014
Additional Clinical Data From The Phase 2 Study With Ablynx (ABLYF)'s Anti-vWF Nanobody, Caplacizumab, Presented At The American Society of Hematology Annual Meeting     12/8/2014
Milestone Pharmaceuticals Announces Positive Phase 1 Data For MSP-2017; Supports Advancement Into Phase 2 In PSVT Patients     11/24/2014
Kaiser Permanente Release: Digoxin Associated With Higher Risk of Death and Hospitalization in Adults With Atrial Fibrillation and No Heart Failure     11/21/2014
NeoStem, Inc. Announces Initial Positive Data From Phase 2 Preserve AMI Clinical Trial     11/18/2014
Capricor Therapeutics, Inc. Announces Favorable ALLSTAR Phase I Safety Results     11/18/2014
Boehringer Ingelheim Pharmaceuticals, Inc. Release: Interim Data Reinforce Safety and Effectiveness of Pradaxa (dabigatran etexilate mesylate) versus Warfarin in Routine Care of Patients with Non-valvular Atrial Fibrillation     11/18/2014
CSL Release: CSL112 Found To Elevate Cholesterol Efflux In Patients With Coronary Artery Disease And Mechanism For Rapid Cholesterol Efflux Capacity Demonstrated     11/18/2014
Abbott Laboratories (ABT) Release: People With Chronic Obstructive Pulmonary Disease (COPD) Who Received Nutrition Treatment In The Hospital Had Better Health Outcomes     11/17/2014
AstraZeneca PLC (AZN) Announces Initiation of Development Program For BRILINTA (ticagrelor) Reversal Agent     11/13/2014
Broad Institute And Massachusetts Institute of Technology (MIT) Defective NPC1L1 Gene Found To Protect Against Heart Disease     11/13/2014
CSL Limited (CMXHF.PK) Launches AEGIS-I, A Phase 2b Clinical Study Of CSL112, A Novel Apolipoprotein A-I Infusion Therapy Designed To Rapidly Remove Cholesterol From Arteries And Stabilize Plaque     11/12/2014
Matinas BioPharma Commences Dosing In First Human Trial Of Lead Product Candidate MAT9001     11/12/2014
Juventas Therapeutics, Inc. Phase 2 Clinical Study Results To Be Presented At 2014 American Heart Association Scientific Sessions     11/12/2014
GlaxoSmithKline (GSK) Survey Points to Rise of COPD in U.S.     11/11/2014

//-->